Wild-type and oncogenic Ras differentially regulate cell proliferation

Slides:



Advertisements
Similar presentations
Figure S1. qPCR analysis of the EMT markers ZEB2 and SNAI1 in Syndecan-1 and control siRNA transfected MDA-MB-231 and MCF-7 cells reveals no significant.
Advertisements

Platelet-Derived Growth Factor-BB Mediates Cell Migration through Induction of Activating Transcription Factor 4 and Tenascin-C  Kristine P. Malabanan,
MMP-2, MT1-MMP, and TIMP-2 are essential for the invasive capacity of human mesenchymal stem cells: differential regulation by inflammatory cytokines by.
SCLCs and LCNECs are sensitive to PARP inhibition in vitro.
Fig. 2. Effects of AZD4785 on proliferation and MAPK pathway signaling in KRAS mutant and wild-type cancer cells in vitro. Effects of AZD4785 on proliferation.
CDK4 is required for the hormone-independent growth of ER+ breast cancer cells. CDK4 is required for the hormone-independent growth of ER+ breast cancer.
PKCK2 determines TRAIL sensitivity.
Loss of SMARCA4 expression or activity derepresses miR-27a.
HIV-1 protease inhibitors decrease proliferation and induce differentiation of human myelocytic leukemia cells by Takayuki Ikezoe, Eric S. Daar, Jun-ichi.
IL6 secretion is a hallmark of postsenescence.
DNAPKcs is required for DNA repair in the presence of androgen.
PDGFRβ is dispensable for EGFRvIII-driven GBM growth but is required for the optimal growth of EGFR-inhibited tumors. PDGFRβ is dispensable for EGFRvIII-driven.
B7-H4 expression correlates with MHC-I expression and improved prognosis in patients with breast cancer. B7-H4 expression correlates with MHC-I expression.
Caspase-1 from myeloid cells induces tumor proliferation via MyD88 oncogenic signaling. Caspase-1 from myeloid cells induces tumor proliferation via MyD88.
A B Supplementary figure S5 ** ** ** ** ** **
NF1 downregulation activates MAPK pathway signaling.
RasGRP3 Mediates MAPK Pathway Activation in GNAQ Mutant Uveal Melanoma
Microarray analysis of phospho-Twist1–responsive genes.
Figure S4 control-siRNA Day 0 fes A-siRNA Day 3 fer 1-siRNA
Identification of metabolic enzymes required for prostate cancer cell survival. Identification of metabolic enzymes required for prostate cancer cell survival.
EGFR is intrinsically active in FGFR3-activated cell lines with combination efficacy from targeting both EGFR and FGFR3. EGFR is intrinsically active in.
An siRNA screen identifies BER pathway members as sensitizers to temozolomide (TMZ) in pediatric GBM. A and B, SJG2 and KNS42 cells were transfected with.
CCL5 and IL-6 promote RAS-driven lung cancer cell proliferation in 3D culture. CCL5 and IL-6 promote RAS-driven lung cancer cell proliferation in 3D culture.
A and B, CO-1686–resistant NCI-H1975 cell clones, COR1-1 and COR10-1 display a reduced dependence on EGFR signaling for survival. A and B, CO-1686–resistant.
ROS induction and ATR inhibition synergize in inducing multiple myeloma (MM) cell death. ROS induction and ATR inhibition synergize in inducing multiple.
eIF5A-PEAK1 signaling regulates KRAS protein expression.
Appearance of prominin-1-containing membrane particles in the culture medium upon differentiation of Caco-2 cells. Appearance of prominin-1-containing.
Specific inhibition of Ras, but not Rac, inhibits EGF-stimulated protrusion. Specific inhibition of Ras, but not Rac, inhibits EGF-stimulated protrusion.
JAK3A572V mutation causes constitutive JAK3 activity and IL-2–independent proliferation of NKTCL cells. JAK3A572V mutation causes constitutive JAK3 activity.
Wild-type NSD3 is required for the blockade of differentiation in BRD4–NUT-expressing NMC cells. Wild-type NSD3 is required for the blockade of differentiation.
Effect of M-cadherin RNAi and GSK-3β inhibition on myogenic differentiation of C2C12 myoblasts. Effect of M-cadherin RNAi and GSK-3β inhibition on myogenic.
Effect of the siRNA-mediated knockdown of endogenous MARCH8 on the expression levels of MARCH8 substrates, TfR and CD98, in HepG2 cells. Effect of the.
Fig. 6. RhoB is required for Rnd3-induced stress fibre formation
BEZ235 induces MAPK signaling in a FOXO3A-dependent manner.
Effect of siRNA transfection on colony formation by Renca cells.
A, B, apoptosis analysis using Annexin V-FITC/PI was done on 5th, 7th, and 9th day after transfection either with si control or si AEBP1in U87MG and U138MG.
c-Rel expression in donor T cells is increased after allo-HSCT.
Inhibition of lung cancer cell proliferation and viability by CYT387.
Induction of CDCP1 is regulated by Ras in NSCLC cells.
Mcl-1 knockdown promotes cleavage of caspase-3 in nonadherent melanoma cells. Mcl-1 knockdown promotes cleavage of caspase-3 in nonadherent melanoma cells.
Sensor siRNAs can be used in high-order combinations.
SiRNA silencing of CDH3, CLDN1, KRT23, and MMP7 (A–D) in adenoma and CRC cell lines significantly reduces cell proliferation. siRNA silencing of CDH3,
Model of ATM-MPG–mediated therapeutic resistance in pGBM.
Inhibitory effect of SFN pretreatment on the TPA-induced transformation of shMock- and shNrf2-transfected JB6 P+ cells. Inhibitory effect of SFN pretreatment.
Inhibitory effects of SFN on the TPA-induced transformation of JB6 P+ cells. Inhibitory effects of SFN on the TPA-induced transformation of JB6 P+ cells.
FOXO-responsive 3X-IRS promoter activity is reduced in LNAI cells versus LNCaP cells. FOXO-responsive 3X-IRS promoter activity is reduced in LNAI cells.
Combination of miR-520d-3p and EphA2 siRNA treatment shows enhanced EphA2 inhibition and antitumor efficiency in vitro. Combination of miR-520d-3p and.
Neurotensin and insulin induce increases in CTGF, CYR61, and CXCL5 gene expression and stimulate cell proliferation and colony via YAP/TAZ in PDAC cells.
Reactivation of epigenetically silenced SMAD1 contributes to chemosensitization. Reactivation of epigenetically silenced SMAD1 contributes to chemosensitization.
The effects of HDAC2 knockdown on cell-cycle proteins.
KRAS mutation leads to resistance to combined RAF/EGFR and RAF/MEK inhibition. KRAS mutation leads to resistance to combined RAF/EGFR and RAF/MEK inhibition.
EGFR signaling regulates transcription of PDGFRβ gene.
Substitution of endogenous Reptin with D299N mutant leads to HuH7 cell growth arrest. Substitution of endogenous Reptin with D299N mutant leads to HuH7.
Knockdown of ERBB3, NRG1, or ERBB2 in H358-TwistER cells reduces basal PI3K–AKT signaling and ablates serum-independent proliferation before EMT. A and.
Effect of NO and eNOS on prostate cancer cell growth.
Transcriptional activity and growth of mutant ER in a breast cancer cell line. Transcriptional activity and growth of mutant ER in a breast cancer cell.
AS1411 alters subcellular distribution of PRMT5 in a time-dependent, dose-dependent, and nucleolin-dependent manner. AS1411 alters subcellular distribution.
HOXA11-AS acts as a ceRNA for miR-1297.
RPL26 is a positive regulator of TP53β splicing.
PARP1 suppresses the transcription of PD-L1 in cancer cells.
CPGL is a growth suppressor in pancreatic cancer cell lines.
ERM proteins promote CD44 cleavage.
Regulation of signaling by wild-type and oncogenic Ras.
A. A. Comparison of transient HSAKIN17 gene silencing induced by either siRNA duplexes or EBV-based siRNA vectors. Twenty-four hours after seeding, HeLa.
Wnt5A and ROR2 contribute to intrinsic resistance to BRAF inhibitors.
CREB1 binds at the proximal region of the TGFB2 promoter and induces its transcriptional activation. CREB1 binds at the proximal region of the TGFB2 promoter.
Combining IGF1R inhibitors with MEK or RAF inhibitors enhances the differential impact upon mutant KRAS cells. Combining IGF1R inhibitors with MEK or RAF.
MYC is required for the hypoxic induction of SHMT2.
D-GM3 promotes uPAR clustering on the cell surface and activates p38 MAPK. A, uPAR expression in cells was either knocked down by treatment with 4 independent.
Sp1 complementation assay.
Presentation transcript:

Wild-type and oncogenic Ras differentially regulate cell proliferation. Wild-type and oncogenic Ras differentially regulate cell proliferation. Cells were transfected with various combinations of siRNAs targeting either the oncogenic or wild-type Ras isoforms. Two days after transfection, cells were counted and seeded in triplicate at equal densities in complete medium. Cell counts were obtained every 24 hours using a Coulter particle counter. An initial cell count was obtained at the time of seeding to confirm equal seeding densities. Values represent the fold-change in cell count relative to the 48-hour timepoint. NS, non-silencing control; H1, H2, H3, 3 independent siRNAs targeting HRAS; K1, K3, 2 independent siRNAs targeting KRAS; N1, N2, N3, 3 independent siRNAs targeting NRAS. Amy Young et al. Cancer Discovery 2013;3:112-123 ©2013 by American Association for Cancer Research